Glibenclamide—10-h Treatment Window in a Clinically Relevant Model of Stroke

Human Recombinant Tissue-Plasminogen Activator (Alteplase): Why Not Use the ‘Human’ Dose for Stroke Studies in Rats?

(2010) Benoît Haelewyn et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Glibenclamide Is Superior to Decompressive Craniectomy in a Rat Model of Malignant Stroke

(2010) J. Marc Simard et al.   STROKE

Use of Telemetry Blood Pressure Transmitters to Measure Intracranial Pressure (ICP) in Freely Moving Rats

(2009) Gergely Silasi et al.   CURRENT NEUROVASCULAR RESEARCH

Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator

(2009) Gregory J. del Zoppo et al.   STROKE

Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations

(2009) Marc Fisher et al.   STROKE

Clot Retrieval for Stroke Should Be Restricted to Clinical Trials

(2009) Anthony J. Furlan   STROKE

Glibenclamide Reduces Inflammation, Vasogenic Edema, and Caspase-3 Activation after Subarachnoid Hemorrhage

(2008) J Marc Simard et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Extension of the Thrombolytic Time Window With Minocycline in Experimental Stroke

(2008) Yoshihiro Murata et al.   STROKE

Protective Effect of Delayed Treatment With Low-Dose Glibenclamide in Three Models of Ischemic Stroke

(2008) J. Marc Simard et al.   STROKE